Abrdn Life Sciences Investors

NYSE:HQL Voorraadrapport

Marktkapitalisatie: US$406.4m

Abrdn Life Sciences Investors Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Dan Omstead

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO23.8yrs
Eigendom CEO0.7%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuur18.8yrs

Recente managementupdates

Recent updates

HQL: Hold Your Investments In This Healthcare CEF For Strong, Steady Yield

Sep 27

HQL: 13% Discount Creates An Opportunity

Jun 29

Tekla Life Sciences raises dividend by 6.5% to $0.33

Feb 15

Tekla Life Sciences declines quarterly dividend by -11.4% to $0.31/share

Nov 16

Tekla Life Sciences Investors: 10% Yield And Trading 10.5% Below NAV

Oct 23

HQL: A Biotechnology Equity CEF With No Leverage

Jul 12

HQL: Buy For The Yield, If You Can Stomach The Depreciation

Apr 27

Tekla Life Sciences Investors: Buy For Steady, Quarterly Dividend

Feb 11

Tekla Life Sciences Investors Rides Biotechnology Wave, Offers Growth With Steady Income

Sep 22

Evaluating Closed-End Funds: HQL Is Another Fine Pick In A Hot Sector

Jun 29

Tekla Life Sciences Investors: 8% Yield, 7% Discount

Jan 09

Tekla Life Sciences declares $0.02 special dividend

Dec 21

Tekla Life Sciences declares $0.40 dividend

Nov 16

CEO

Dan Omstead (71 yo)

23.8yrs

Tenure

Dr. Daniel R. Omstead serves as Director at HotSpot Therapeutics, Inc. since April 2021. Dr. Omstead serves as the President since 2001, Chief Executive Officer, Chief Financial Officer, Manager, Trustee,...

Bestuursleden

NaamPositieTenureCompensatieEigendom
Daniel Omstead
Principal Executive Officer21.8yrsgeen gegevens0.72%
$ 2.9m
Michael Bonney
Trustee13.8yrsUS$26.50kgeen gegevens
Oleg Pohotsky
Chairman24.8yrsUS$34.50kgeen gegevens
Uwe Reinhardt
Independent Trustee32.8yrsUS$23.50kgeen gegevens
William Reardon
Trustee14.8yrsUS$30.75kgeen gegevens
Lucinda Stebbins
Independent Trustee18.8yrsUS$28.00kgeen gegevens
Rakesh Jain
Trustee17.8yrsUS$24.00kgeen gegevens
Rose DiMartino
Trusteeno datageen gegevens0.0037%
$ 14.9k

18.8yrs

Gemiddelde duur

75.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van HQL zijn ervaren en ervaren (gemiddelde ambtstermijn van 18.8 jaar).